The British HIV Association (BHIVA) guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2012 are now online in draft.
The scope of this document includes guidance on the initiation of ART in those previously naive to therapy, support of patients on treatment, management of patients experiencing virological failure and recommendations in specific patient populations where other factors need to be taken into consideration.
The Treatment Guidelines Writing Group is grateful for all comments, which will be reviewed before publication.
Comments can be made online at the same URL for the draft document:
These guidelines have been produced based using a new methodology and grading system compared to earlier documents, and are clearly the result of considerable additional work.
The evidence base is published in a separate 270-page appendix.
Of note, some of the recommendations in the current draft include differences between the BHIVA writing committee and current prescribing by the London consortium.
Readers have until 5 March to comment.
Links to external websites are current at time of posting but not maintained.